Simvastatin
Showing 1 - 25 of 723
Pulp Exposure, Dental Trial in Minya (Simvastatin)
Recruiting
- Pulp Exposure, Dental
- Simvastatin
-
Minya, EgyptFaculty of Dentistry
May 17, 2023
Recurrent Acute Pancreatitis, Chronic Pancreatitis Trial (Simvastatin, Placebo)
Not yet recruiting
- Recurrent Acute Pancreatitis
- Chronic Pancreatitis
- Simvastatin
- Placebo
- (no location specified)
Mar 14, 2023
Dental Caries Extending to Pulp, Dental Implant Failed Trial in Cairo (Simvastatin)
Completed
- Dental Caries Extending to Pulp
- Dental Implant Failed
- Simvastatin
-
Cairo, EgyptThe British University in Egypt
Sep 1, 2023
Pulpitis - Irreversible Trial in Ismailia (Biodentine, Simvastatin)
Completed
- Pulpitis - Irreversible
- Biodentine
- Simvastatin
-
Ismailia, EgyptFaculty of dentistry, Suez canal university
Oct 12, 2022
Triple Negative Breast Cancer, Chemo Effect, Simvastatin Adverse Reaction Trial in Jakarta Pusat (Simvastatin 40mg, Placebo)
Recruiting
- Triple Negative Breast Cancer
- +2 more
- Simvastatin 40mg
- Placebo
-
Jakarta Pusat, DKI Jakarta, IndonesiaDr. Cipto Mangunkusumo National Central General Hospital
Sep 22, 2022
Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))
Not yet recruiting
- Pancreatic Cancer Metastatic
- C3 (Metformin, Simvastatin, and Digoxin)
- (no location specified)
Sep 1, 2023
Olfactory Disorder, COVID-19 Trial (Simvastatin)
Not yet recruiting
- Olfactory Disorder
- COVID-19
- Simvastatin
- (no location specified)
Sep 13, 2022
Healthy Trial in Tempe (Simvastatin, Rosuvastatin, MGL-3196)
Completed
- Healthy
- Simvastatin
- +2 more
-
Tempe, ArizonaCelerion
Aug 31, 2022
Dilated Cardiomyopathy Trial in Taipei (Simvastatin)
Completed
- Dilated Cardiomyopathy
- Simvastatin
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 2, 2022
Endometriosis Trial in New Haven (simvastatin 10mg, Bazedoxifene 20/Estrogens,Con 0.45Mg Tb, Placebo)
Recruiting
- Endometriosis
- simvastatin 10mg
- +2 more
-
New Haven, ConnecticutThe John B. Pierce Laboratory
Dec 8, 2022
Cirrhosis, Hepatic Encephalopathy, Ascites Trial (Allopurinol 300 MG, Simvastatin 40mg, Placebo)
Not yet recruiting
- Cirrhosis
- +4 more
- Allopurinol 300 MG
- +2 more
- (no location specified)
Aug 22, 2022
Traumatic Brain Injury Trial (Simvastatin, Placebo drug)
Not yet recruiting
- Traumatic Brain Injury
- Simvastatin
- Placebo drug
- (no location specified)
Oct 6, 2022
Metabolic Syndrome Trial in Houston (Simvastatin, Vytorin, Placebo)
Completed
- Metabolic Syndrome
- Simvastatin
- +3 more
-
Houston, TexasBaylor College of Medicine
Jul 21, 2022
Periodontitis Trial in Cairo (Lepidium Sativum, Simvastatin)
Completed
- Periodontitis
- Lepidium Sativum
- Simvastatin
-
Cairo, EgyptFaculty of Dentitry, Ain Shams University
Dec 10, 2022
Adenocarcinoma of the Pancreas Trial in Italy, Spain (Valproic acid, Simvastatin 20mg, Gemcitabine 1000 mg)
Not yet recruiting
- Adenocarcinoma of the Pancreas
- Valproic acid
- +4 more
-
Milano, Italy
- +4 more
Apr 6, 2023
Atherosclerosis, Hypercholesterolemia, Hyperlipoproteinemia Type II Trial (ezetimibe (plus simvastatin), (plus simvastatin))
Completed
- Atherosclerosis
- +2 more
- ezetimibe (plus simvastatin)
- placebo (plus simvastatin)
- (no location specified)
Feb 7, 2022
Hypercholesterolemia, Coronary Disease Trial (Ezetimibe/Simvastatin 10/20 mg, simvastatin 40 mg)
Completed
- Hypercholesterolemia
- Coronary Disease
- Ezetimibe/Simvastatin 10/20 mg
- simvastatin 40 mg
- (no location specified)
Feb 7, 2022
Hypercholesterolaemia, Atherosclerosis Trial (Ezetimibe + Simvastatin, Simvastatin)
Completed
- Hypercholesterolaemia
- Atherosclerosis
- Ezetimibe + Simvastatin
- Simvastatin
- (no location specified)
Feb 7, 2022
Obesity, Hyperlipidemias Trial in Singapore (Simvastatin)
Recruiting
- Obesity
- Hyperlipidemias
- Simvastatin
-
Singapore, SingaporeNational University Hospital
Apr 7, 2022
Coronary Disease Trial (MK0653, ezetimibe / Duration of Treatment: 27 Weeks, MK0733, simvastatin / Duration of Treatment: 27
Completed
- Coronary Disease
- MK0653, ezetimibe / Duration of Treatment: 27 Weeks
- +2 more
- (no location specified)
Feb 7, 2022
Cardiovascular Disorder, Diabetes Trial (ezetimibe (+) simvastatin, simvastatin 40 mg or atorvastatin 20 mg, Rosuvastatin)
Completed
- Cardiovascular Disorder
- Diabetes Mellitus
- ezetimibe (+) simvastatin
- +3 more
- (no location specified)
Feb 7, 2022
Diabetes, Type 2 Trial (MK0653, ezetimibe / Duration of Treatment: 30 Weeks, Comparator : ezetimibe (+) simvastatin / Duration
Completed
- Diabetes Mellitus, Type 2
- MK0653, ezetimibe / Duration of Treatment: 30 Weeks
- Comparator : ezetimibe (+) simvastatin / Duration of Treatment: 30 Weeks
- (no location specified)
Feb 7, 2022
Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer Trial in Washington, Baltimore (Simvastatin,
Active, not recruiting
- Breast Cancer
- +3 more
- Simvastatin
- Doxorubicin/cyclophosphamide
-
Washington, District of Columbia
- +1 more
May 19, 2022
Hypercholesterolemia, Diabetes, Type 2, Coronary Disease Trial (Ezetimibe 10 mg, Simvastatin 20 mg, Ezetimibe Placebo)
Completed
- Hypercholesterolemia
- +2 more
- Ezetimibe 10 mg
- +3 more
- (no location specified)
Feb 7, 2022
Coronavirus Infection Trial in Madrid (Ruxolitinib plus simvastatin, Standard of Care)
Completed
- Coronavirus Infection
- Ruxolitinib plus simvastatin
- Standard of Care
-
Madrid, SpainHospital Universitario Madrid Sanchinarro
Jun 3, 2022